Article
Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients.
Alimentary pharmacology & therapeutics - 1 Jul 2009
Iacobellis A, Siciliano M, Annicchiarico B E, Valvano M R, Niro G A, Accadia L, Caruso N, Bombardieri G, Andriulli A
Abstract excerpt
BACKGROUND: Little data is available about predictors of sustained virological response (SVR) during anti-viral therapy of patients with decompensated HCV cirrhosis. AIMS: To determine whether rapid and early virological responses (RVR and EVR) could predict SVR and help optimize treatment in these patients. METHODS: A total of 94 cirrhotics underwent treatment with peg-interferon alfa-2b (1.5 microg/kg weekly)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
